ARTICLE | Clinical News
Gensia Inc. regulatory update
September 16, 1996 7:00 AM UTC
The FDA approved an ANDA from GNSA’s Gensia Laboratories Ltd. subsidiary for fluphenazine decanoate injection to treat schizophrenia. The approval marks the 24th generic product in Gensia Laboratories...